Suppr超能文献

S-腺苷-L-甲硫氨酸合成酶和磷脂甲基转移酶在人类肝硬化中受到抑制。

S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis.

作者信息

Duce A M, Ortíz P, Cabrero C, Mato J M

机构信息

Metabolismo, Nutrición y Hormonas, Fundación, Jiménez Díaz, Madrid, Spain.

出版信息

Hepatology. 1988 Jan-Feb;8(1):65-8. doi: 10.1002/hep.1840080113.

Abstract

We have measured the activity S-adenosyl-L-methionine synthetase in liver biopsies from a group of controls (n = 17) and in 26 cirrhotics (12 alcoholic and 14 posthepatic). The activity of this enzyme was markedly reduced in the group of cirrhotics (285 +/- 32 pmoles per min per mg protein) when compared with that observed in controls (505 +/- 37 pmoles per min per mg protein). No differences in S-adenosyl-L-methionine synthetase was observed between both groups of cirrhotics. Similarly, a marked reduction in the activity phospholipid methyltransferase was also observed in liver biopsies from the same group of cirrhotics (105 +/- 12 pmoles per min per mg protein) when compared with the control subjects (241 +/- 13 pmoles per min per mg protein). Again, no difference in the activity of this enzyme was observed between both groups of cirrhotics. These results indicated a marked deficiency in the metabolism of S-adenosyl-L-methionine in cirrhosis.

摘要

我们测定了一组对照组(n = 17)以及26名肝硬化患者(12名酒精性肝硬化患者和14名肝后性肝硬化患者)肝脏活检组织中S-腺苷-L-甲硫氨酸合成酶的活性。与对照组(每分钟每毫克蛋白质505±37皮摩尔)相比,肝硬化患者组该酶的活性显著降低(每分钟每毫克蛋白质285±32皮摩尔)。两组肝硬化患者之间未观察到S-腺苷-L-甲硫氨酸合成酶活性的差异。同样,与对照受试者(每分钟每毫克蛋白质241±13皮摩尔)相比,同一组肝硬化患者肝脏活检组织中磷脂甲基转移酶的活性也显著降低(每分钟每毫克蛋白质105±12皮摩尔)。两组肝硬化患者之间该酶的活性同样未观察到差异。这些结果表明肝硬化患者中S-腺苷-L-甲硫氨酸代谢存在明显缺陷。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验